Back to Search
Start Over
Clinical features and current treatment status of essential thrombocythemia in older adults: a multicenter real-world study in China.
- Source :
- Annals of Hematology; Aug2023, Vol. 102 Issue 8, p2097-2107, 11p
- Publication Year :
- 2023
-
Abstract
- Approximately half of patients diagnosed with essential thrombocythemia (ET) are older adults (aged ≥ 60 years), but to date, little is known about the clinical and molecular characteristics of older patients diagnosed according to the 2016 World Health Organization criteria. We retrospectively collected clinical and molecular data from 282 older (≥ 60 years) and 621 younger ET patients (18–59 years) in China from March 1, 2012 to November 1, 2021 and summarized the clinical characteristics and treatment of these older ET patients. Compared to younger patients, older patients had a higher incidence of the JAK2V617F mutation (P = 0.001), a lower incidence of CALR mutations (P = 0.033) and a higher rate of epigenetic mutations (P < 0.001), TP53 mutations (P = 0.005), and RNA splicing mutations (P < 0.001). Older patients had not only a higher incidence of thrombosis but also a higher incidence of bleeding events. Furthermore, older patients had a significantly higher mortality rate after disease progression (P = 0.050) or after thrombotic events (P = 0.013). Risk factors for thrombosis or prognosis were significantly different between older patients and the entire ET cohort. In older patients, non-driver mutations contributed significantly to thrombotic complications and a poor prognosis, while the JAK2V617F mutation was a risk factor for overall survival but not for thrombotic events. The application of interferon in older ET patients was not inferior to that of hydroxyurea in terms of efficacy and safety. Older patients presented unique characteristics different from those of younger patients, which could provide new information for formulating more appropriate treatment and follow-up strategies. [ABSTRACT FROM AUTHOR]
- Subjects :
- OLDER people
OLDER patients
THROMBOCYTOSIS
RNA splicing
OVERALL survival
Subjects
Details
- Language :
- English
- ISSN :
- 09395555
- Volume :
- 102
- Issue :
- 8
- Database :
- Complementary Index
- Journal :
- Annals of Hematology
- Publication Type :
- Academic Journal
- Accession number :
- 164899662
- Full Text :
- https://doi.org/10.1007/s00277-023-05317-z